Adult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: A new model for dilated cardiomyopathy

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 87, Issue 8, 2011, Pages 550-562

  Suzuki, Osamu ^a   Kanai, Takao ^b   Nishikawa, Toshio ^b   Yamamoto, Yoshie ^c   Noguchi, Akira ^c   Takimoto, Kazuhiro ^c   Koura, Minako ^a   Noguchi, Yoko ^a   Uchio Yamada, Kozue ^a   Tsuji, Shuichi ^d   Matsuda, Junichiro ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

Calnexin; Calreticulin; Cardiac dilatation; Cardiomyopathy; ER stress; ST3Gal II

Indexed keywords

BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; CALNEXIN; CALRETICULIN; GANGLIOSIDE; LECTIN; SIALYLTRANSFERASE;

AGING; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; C57BL MOUSE; CONGESTIVE CARDIOMYOPATHY; DISEASE MODEL; ENZYMOLOGY; FROZEN SECTION; GENETICS; HEART MUSCLE; HOMOZYGOTE; METABOLISM; MOUSE; PATHOLOGY; STAINING; TRANSGENE; TRANSGENIC MOUSE;

AGING; ANIMALS; CALNEXIN; CALRETICULIN; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; FROZEN SECTIONS; GANGLIOSIDES; HOMOZYGOTE; LECTINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; ORGAN SPECIFICITY; SIALYLTRANSFERASES; STAINING AND LABELING; TRANSGENES;

EID: 82355187651     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.87.550     Document Type: Article

References (39)

1. Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, E., Thiene, G., Goodwin, J., Gyarfas, I., Martin, I. and Nordet, P. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Denition and Classication of cardiomyopathies. Circulation 93, 841-842.
2. Lee, Y.C., Kurosawa, N., Hamamoto, T., Nakaoka, T. and Tsuji, S. (1993) Molecular cloning and expression of Galβ1,3GalNAc α2,3-sialyltransferase from mouse brain. Eur. J. Biochem. 216, 377-385.
3. Lee, Y.C., Kojima, N., Wada, E., Kurosawa, N., Nakaoka, T., Hamamoto, T. and Tsuji, S. (1994) Cloning and expression of cDNA for a new type of Galβ1,3GalNAc α2,3-sialyltransferase. J. Biol. Chem. 269, 10028-10033.
4. Kono, M., Ohyama, Y., Lee, Y.C., Hamamoto, T., Kojima, N. and Tsuji, S. (1997) Mouse O-galactoside α2,3-sialyltransferases: comparison of in vitro substrate specicities and tissue specic expression. Glycobiology 7, 469-479.
5. Fukumoto, S., Miyazaki, H., Goto, G., Urano, T. and Furukawa, K. (1999) Expression cloning of mouse cDNA of CMP-NeuAc:Lactosylceramide α2,3sialyltransferase, an enzyme that initiates the synthesis of gangliosides. J. Biol. Chem. 274, 9271-9276.
6. Okajima, T., Fukumoto, S., Miyazaki, H., Ishida, H., Kiso, M., Furukawa, K. and Urano, T. (1999) Molecular cloning of a novel,2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J. Biol. Chem. 274, 11479-11486.
7. Kojima, N., Lee, Y.C., Hamamoto, T., Kurosawa, N. and Tsuji, S. (1994) Kinetic properties and acceptor substrate preferences of two kinds of Galβ1,3- GalNAc α2,3-sialyltransferase from mouse brain. Biochemistry 33, 5772-5776.
8. Ellies, L.G., Sperandio, M., Underhill, G.H., Yousif, J., Smith, M., Priatel, J.J., Kansas, G.S., Ley, K. and Marth, J.D. (2002) Sialyltransferase specicity in selectin ligand formation. Blood 100, 3618-3625.
9. Kim, Y.J., Kim, K.S., Kim, S.H., Kim, C.H., Ko, J.H., Choe, I.S., Tsuji, S. and Lee, Y.C. (1996) Molecular cloning and expression of human Galβ1,3GalNAc α2,3-sialyltransferase (hST3Gal II). Biochem. Biophys. Res. Commun. 228, 324-327.
10. Kopito, R.R. (1997) ER quality control: the cytoplasmic connection. Cell 88, 427-430.
11. Michalak, M., Corbett, E.F., Mesaeli, N., Nakamura, K. and Opas, M. (1999) Calreticulin: one protein, one gene, many functions. Biochem. J. 344 (Pt 2), 281-292.
12. Wada, I., Rindress, D., Cameron, P.H., Ou, W.J., Doherty, J.J., Louvard, D., Bell, A.W., Dignard, D., Thomas, D.Y. and Bergeron, J.J. (1991) SSR, and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane. J. Biol. Chem. 266, 19599-19610.
13. Niwa, H., Yamamura, K. and Miyazaki, J. (1991) Effcient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
14. Noguchi, A., Takekawa, N., Einarsdottir, T., Koura, M., Noguchi, Y., Takano, K., Yamamoto, Y., Matsuda, J. and Suzuki, O. (2004) Chromosomal mapping and zygosity check of transgenes based on anking genome sequences determined by genomic walking. Exp. Anim. 53, 103-111.
15. Folch, J., Lees, M. and Stanley, G.H.S. (1957) A simple method for the isolation and purication of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
16. Williams, M.A. and McCluer, R.H. (1980) The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J. Neurochem. 35, 266-269.
17. Svennerholm, L. (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta 24, 604-611.
18. Sakamoto, A., Ono, K., Abe, M., Jasmin, G., Eki, T., Murakami, Y., Masaki, T., Toyo-oka, T. and Hanaoka, F. (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, /-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. U. S. A. 94, 13873-13878.
19. Towbin, J.A. and Bowles, N.E. (2002) The failing heart. Nature 415, 227-233.
20. Leskawa, K.C. and Short, C.S. (1988) Glycolipids of cardiac muscle: an interspecies comparison. Glycoconj. J. 5, 302.
21. Müthing, J. and Čačić, M. (1997) Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography. Glycoconj. J. 14,19-28.
22. Jin, Z.Q., Zhou, H.Z., Zhu, P., Honbo, N., Mochly-Rosen, D., Messing, R.O., Goetzl, E.J., Karliner, J.S. and Gray, M.O. (2002) Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCC knockout mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 282, H1970-H1977.
23. Dairaku, K., Miyagi, T., Wakui, A. and Tsuiki, S. (1986) Cytosolic sialidases of rat tissues with special reference to skeletal muscle enzyme. Biochem. Int. 13, 741-748.
24. Saito, S., Aoki, H., Ito, A., Ueno, S., Wada, T., Mitsuzuka, K., Satoh, M., Arai, Y. and Miyagi, T. (2003) Human,2,3-sialyltransferase (ST3Gal II) is a stage-specic embryonic antigen-4 synthase. J. Biol. Chem. 278, 26474-26479.
25. Rabouille, C., Hui, N., Hunte, F., Kieckbusch, R., Berger, E.G., Warren, G. and Nilsson, T. (1995) Mapping the distribution of Golgi enzymes involved in the construction of complex oligosaccharides. J. Cell Sci. 108, 1617-1627.
26. Giraudo, C.G., Rosales Fritz, V.M. and Maccioni, H.J. (1999) GA2/GM2/GD2 synthase localizes to the trans-Golgi network of CHO-K1 cells. Biochem. J. 342, 633-640.
27. Teasdale, R.D., Matheson, F. and Gleeson, P.A. (1994) Post-translational modications distinguish cell surface from Golgi-retained β1,4 galactosyltransferase molecules. Golgi localization involves active retention. Glycobiology 4, 917-928.
28. 2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32, 269-278.
29. Zapun, A., Darby, N.J., Tessier, D.C., Michalak, M., Bergeron, J.J. and Thomas, D.Y. (1998) Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem. 273, 6009-6012.
30. Dedhar, S., Rennie, P.S., Shago, M., Hagesteijn, C.Y., Yang, H., Filmus, J., Hawley, R.G., Bruchovsky, N., Cheng, H., Matusik, R.J. and Giguère, V. (1994) Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367, 480-483.
31. Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K.H., Opas, M., MacLennan, D.H. and Michalak, M. (1999) Calreticulin is essential for cardiac development. J. Cell Biol. 144, 857-868.
32. Papp, S., Zhang, X., Szabo, E., Michalak, M. and Opas, M. (2008) Expression of endoplasmic reticulum chaperones in cardiac development. Open Cardiovasc. Med. J. 2,31-35.
33. Hattori, K., Nakamura, K., Hisatomi, Y., Matsumoto, S., Suzuki, M., Harvey, R.P., Kurihara, H., Hattori, S., Yamamoto, T., Michalak, M. and Endo, F. (2007) Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. Mol. Genet. Metab. 91, 285-293.
34. Nakamura, K., Robertson, M., Liu, G., Dickie, P., Guo, J.Q., Duff, H.J., Opas, M., Kavanagh, K. and Michalak, M. (2001) Complete heart block and sudden death in mice overexpressing calreticulin. J. Clin. Invest. 107, 1245-1253.
35. Kageyama, K., Ihara, Y., Goto, S., Urata, Y., Toda, G., Yano, K. and Kondo, T. (2002) Overexpression of calreticulin modulates protein kinase B/Akt signaling to promote apoptosis during cardiac differentiation of cardiomyoblast H9c2 cells. J. Biol. Chem. 277, 19255-19264.
36. Ihara, Y., Urata, Y., Goto, S. and Kondo, T. (2006) Role of calreticulin in the sensitivity of myocardiac H9c2 cells to oxidative stress caused by hydrogen peroxide. Am. J. Physiol. Cell Physiol. 290, C208-C221.
37. Chang, S.C., Wooden, S.K., Nakaki, T., Kim, Y.K., Lin, A.Y., Kung, L., Attenello, J.W. and Lee, A.S. (1987) Rat gene encoding the 78-kDa glucoseregulated protein GRP78: its regulatory sequences and the effect of protein glycosylation on its expression. Proc. Natl. Acad. Sci. U. S. A. 84, 680-684.
38. Shintani-Ishida, K., Nakajima, M., Uemura, K. and Yoshida, K. (2006) Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78. Biochem. Biophys. Res. Commun. 345, 1600-1605.
39. Meyer, M., Schillinger, W., Pieske, B., Holubarsch, C., Heilmann, C., Posival, H., Kuwajima, G., Mikoshiba, K., Just, H. and Hasenfuss, G. (1995) Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92, 778-784.